ACTA NEUROPHARMACOLOGICA ›› 2021, Vol. 11 ›› Issue (6): 17-.DOI: 10.3969/j.issn.2095-1396.2021.06.003

Previous Articles     Next Articles

Prediction of Core Targets of Umbilical Cord Mesenchymal Stem Cells for Breast Cancer Treatment

YOU Si-han,GUO Chun-yan   

  1. Department of Pharmacy,Hebei North University,Zhangjiakou,075000,China
  • Online:2021-12-26 Published:2021-12-26

Abstract:

Objective:Using network databases and bioinformatics technology platforms,analyze the data of Umbilical cord mesenchymal stem cells (UC-MSCs) in the treatment of breast cancer (BC),and predict the core target of UC-MSCs in the treatment of BC. Methods:Use the GEO database in NCBI (www.ncbi.com.cn) to search the original data set GSE64827 of UC-MSCs treatment of BC. Then use R software to standardize the data to obtain differential genes;use STRING database to perform protein-protein interaction function network analysis and topology analysis,use DAVID online tools and R software to carry out GO enrichment analysis and KEGG pathway analysis of related genes. Results:Using R software to screen out 11 differential genes,do network analysis and topological analysis of their protein-protein interactions (relevant genes with confidence greater than or equal to 0.7),suggesting the association degree of ALDOC,IGFBP3,DDIT4 and PFKFB4 is higher. GO analysis and annotation obtained 3 biological processes,namely fructose metabolism process,glycolysis process and hypoxia reaction process. The main genes involved are PFKFB4,ALDOC,DDIT4 and CA9. KEGG pathway analysis yielded a fructose and mannose metabolic pathway,involving genes ALDOC and PFKFB4. Conclusion:This study uses network databases and bioinformatics technology platforms to predict that the core targets of UC-MSCs for breast cancer treatment are ALDOC,PFKFB4 and DDIT4.

Key words: umbilical cord mesenchymal stem cells, breast cancer, network pharmacology, bioinformatics clinical trials

CLC Number: